COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 671

Article download: 176

IP Indian Journal of Immunology and Respiratory Medicine


Allergic Bronchopulmonary Aspergillosis (ABPA) – Asthma on the tip of iceberg


Full Text PDF Share on Facebook Share on Twitter


Author Details : Harshpreet Singh Tuteja, Sourya Acharya, Samarth Shukla

Volume : 2, Issue : 4, Year : 2017

Article Page : 108-110


Suggest article by email

Abstract

Allergic Bronchopulmonary Aspergillosis (ABPA) is one of the rare presentations of fungus Aspergillus fumigatus.  Apart from ABPA two other manifestations are aspergilloma and aspergillus asthma. ABPA classically presents as central bronchiectasis which is not seen in asthma. We present a case of ABPA masquerading as chronic asthma. This case highlights on the bizarre presentations of ABPA. Weather it presents primarily with symptoms of asthma, or it can present itself superimposed on clinical asthma. The dilemma begins when ABPA presents with asthma without any radiologic evidence. Usually these cases are initially treated as asthma only, later on when the symptoms are not improved with proper asthma therapy and/or till they develop radiologic abnormality.

Keywords: ABPA; Aspergilloma; Asthma; Radiologic

How to cite : Tuteja H S, Acharya S, Shukla S, Allergic Bronchopulmonary Aspergillosis (ABPA) – Asthma on the tip of iceberg. IP Indian J Immunol Respir Med 2017;2(4):108-110

Copyright © 2017 by author(s) and IP Indian J Immunol Respir Med. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)